Status:

COMPLETED

Substance Use and Loneliness

Lead Sponsor:

VA Office of Research and Development

Conditions:

Substance Use Disorders

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Background: Loneliness-a subjective emotional state characterized by the perception of social isolation-is a psychosocial factor that is associated with increased mortality, substance use, and is asso...

Eligibility Criteria

Inclusion

  • Participants must be ages 18+,
  • understand English,
  • have access to a phone or computer,
  • screen positive for an active, at least moderate SUD. SUD include alcohol, marijuana, opioids, cocaine, other psychomotor stimulants (methamphetamine, amphetamines), and sedative/hypnotic/anxiolytic use disorders.
  • Participants will need to screen positive for loneliness.

Exclusion

  • Participant with significant cognitive impairment will be excluded.

Key Trial Info

Start Date :

September 30 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT05338268

Start Date

September 30 2022

End Date

December 31 2024

Last Update

January 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA Finger Lakes Healthcare System, Canandaigua, NY

Canandaigua, New York, United States, 14424-1159